相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Margaret Nieborowska-Skorska et al.
BLOOD (2012)
Lower Phosphorylation of p38 MAPK Blocks the Oxidative Stress-induced Senescence in Myeloid Leukemic CD34+CD38- Cells
Yin Xiao et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)
Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients
F. X. Gruber et al.
LEUKEMIA (2012)
BCR/ABL Stimulates WRN to Promote Survival and Genomic Instability
Artur Slupianek et al.
CANCER RESEARCH (2011)
The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
Christopher A. Eide et al.
CANCER RESEARCH (2011)
BCR-ABL1 Kinase: Hunting an Elusive Target with New Weapons
Tomasz Skorski
CHEMISTRY & BIOLOGY (2011)
Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state
Tomasz Skorski
LEUKEMIA & LYMPHOMA (2011)
Predicting the Response of CML Patients to Tyrosine Kinase Inhibitor Therapy
Deborah L. White et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2011)
Chronic myeloid leukemia: mechanisms of blastic transformation
Danilo Perrotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype
H. Grant et al.
LEUKEMIA (2010)
Incorporation of dUTP does not mediate mutation of A:T base pairs in Ig genes in vivo
George Sharbeen et al.
NUCLEIC ACIDS RESEARCH (2010)
Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia
Letizia Foroni et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Uracil in DNA and its processing by different DNA glycosylases
Torkild Visnes et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations
Tomasz Stoklosa et al.
CANCER RESEARCH (2008)
BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress
M. Koptyra et al.
LEUKEMIA (2008)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells
Xiaoyan Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib
Ian J. Griswold et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
Mateusz Koptyra et al.
BLOOD (2006)
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients; correlation with clonal cytogenetic evolution but not response to therapy
SG Willis et al.
BLOOD (2005)
Chronic myeloid leukaemia: stem cell derived but progenitor cell driven
SB Marley et al.
CLINICAL SCIENCE (2005)
BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks
MO Nowicki et al.
BLOOD (2004)
Mutational analysis of the damage-recognition and catalytic mechanism of human SMUG1 DNA glycosylase
M Matsubara et al.
NUCLEIC ACIDS RESEARCH (2004)
DNA polymerase beta overexpression stimulates the Rad51-dependent homologous recombination in mammalian cells
Y Canitrot et al.
NUCLEIC ACIDS RESEARCH (2004)
Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia
N Sorel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib
HK Al-Ali et al.
HEMATOLOGY JOURNAL (2004)
p210 BCR/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation
Y Canitrot et al.
BLOOD (2003)
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
S Branford et al.
BLOOD (2003)
Free radical scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells
J Blasiak et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2003)
Uracil in DNA - occurrence, consequences and repair
HE Krokan et al.
ONCOGENE (2002)
A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue
M Takao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
HUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup
B Kavli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions
TK Hazra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis
M Nieborowska-Skorska et al.
BLOOD (2002)
Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G2/M phase, and protection from apoptosis
A Slupianek et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
S Branford et al.
BLOOD (2002)
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance
A Slupianek et al.
MOLECULAR CELL (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Excision of deaminated cytosine from the vertebrate genome: role of the SMUG1 uracil-DNA glycosylase
H Nilsen et al.
EMBO JOURNAL (2001)
The contribution of endogenous sources of DNA damage to the multiple mutations in cancer
AL Jackson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Spontaneous DNA damage, genome instability, and cancer -: When DNA replication escapes control
P Schär
CELL (2001)
Repair of oxidative DNA damage - Mechanisms and functions
AL Lu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2001)
Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage
S Mitra et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2001)
Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase
F Petronzelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Nucleotide excision repair DNA synthesis by excess DNA polymerase β:: a potential source of genetic instability in cancer cells
Y Canitrot et al.
FASEB JOURNAL (2000)